Surrogate Markers of Antiangiogenic Therapies

doi 10.2174/978160805007911001010190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BENTHAM SCIENCE PUBLISHERS

Related search

Surrogate Markers for Cardiovascular Disease: Structural Markers

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma

Journal of Oncology
Oncology
2012English

NMR With Combined Antiangiogenic and Radiation Therapies - Breast Cancer

2000English

NMR With Combined Antiangiogenic and Radiation Therapies - Breast Cancer

2002English

The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis Under Lipid Lowering Therapies

Cholesterol
Organic ChemistryInternal MedicineEndocrinologyHematologyMetabolismDiabetes
2017English

Lymphocyte Subsets as Surrogate Markers in Antiretroviral Therapy

Infection
MedicineInfectious DiseasesMicrobiology
1991English

Serum DNA Microsatellites as Surrogate Genetic Markers of Breast Cancer Progression

2002English

Biochemical Markers of Synovial Inflammation – Surrogate Markers of Synovitis on Magnetic Resonance Imaging? – Data From the Osteoarthritis Initiative

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2016English

Porcine Blood and Surrogate Markers Do Not Prove Benefit of aDabi-Fab

Critical Care
Critical CareIntensive Care Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy